Sage Journals: Discover world-class research

Abstract

Objective

To evaluate the safety and efficacy of MicroPulse Transscleral Laser Therapy (MicroPulse TLT) with the Revised P3^® Delivery Device.

Design

Prospective, single-surgeon, interventional study in a tertiary hospital setting.

Participants

Sixty-two eyes of 40 patients with refractory glaucoma.

Methods

All subjects received 360-degree MicroPulse TLT treatment (2500 mW, 31.33% duty cycle) over a total of 240 s (8 sweeps; n = 20), 300 s (10 sweeps; n = 22), or 200 s (10 sweeps; n = 20). Participants were followed up for 6 months to assess changes in intraocular pressure (IOP), glaucoma medication burden, and best-corrected visual acuity (BCVA). Surgical success was defined as a reduction of IOP ≥ 30% from baseline and between 6–18 mmHg at last follow-up with no additional anti-glaucoma medications or secondary reinterventions.

Results

Surgical success was achieved in 72.7% (300 s group), 75.0% (240 s group), and 80.0% (200 s group) of eyes. Mean IOP was significantly reduced (p < 0.001) by 49.0% (300 s group), 45.66% (240 s group), and 39.8% (200 s group) at 6 months. With all groups combined, the mean number of glaucoma medications was significantly reduced by 17.8% (p = 0.005), and no significant changes in BCVA were observed at 6 months. Complications were minimal, including four eyes with IOP spikes, one eye with hyphema, and one eye with cystoid macular edema (CME), all of which resolved. Two eyes of the total sample (3.2%) required secondary glaucoma surgery before 6 months.

Conclusions

Second-generation MicroPulse TLT at fluence values of 154–229 J/cm² appears to be a safe and effective option for IOP reduction in refractory glaucoma.

Keywords

Laser surgery < GLAUCOMA open angle glaucoma < GLAUCOMA angle closure < GLAUCOMA aqueous humor dynamics < GLAUCOMA GLAUCOMA

Get full access to this article

View all access options for this article.

References

Tham

Wong

, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121: 2081–2090. DOI:https://doi.org/10.1016/j.ophtha.2014.05.013

Wagner

Stewart

Dorairaj

. Updates on the diagnosis and management of glaucoma. Mayo Clin Proc Innov Qual Outcomes 2022; 6: 618–635. DOI:https://doi.org/10.1016/j.mayocpiqo.2022.09.007

Craven

Singh

, et al. Reoperation rates and disease costs for primary open-angle glaucoma patients in the United States treated with incisional glaucoma surgery. Ophthalmol Glaucoma 2022; 5: 297–305. DOI:https://doi.org/10.1016/j.ogla.2021.10.011

Jampel

Solus

Tracey

, et al. Outcomes and bleb-related complications of trabeculectomy. Ophthalmology 2012; 119: 712–722. DOI:https://doi.org/10.1016/j.ophtha.2011.09.049

Pantalon

Feraru

Tarcoveanu

, et al. Success of primary trabeculectomy in advanced open angle glaucoma. Clin Ophthalmol 2021; 15: 2219–2229. DOI:https://doi.org/10.2147/opth.S308228

Gurnani

Tripathy

Tan

Chockalingam

Aquino

, et al. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol 2010; 38: 266–272. DOI:https://doi.org/10.1111/j.1442-9071.2010.02238.x

Souissi

Le Mer

Metge

, et al. An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma. Acta Ophthalmol 2021; 99: e621–e653. DOI:https://doi.org/10.1111/aos.14661

Kaba

Somani

Tam

, et al. The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma. Ophthalmol Glaucoma 2020; 3: 181–189. DOI:https://doi.org/10.1016/j.ogla.2020.02.005

10.

Magacho

Lima

Ávila

. Double-session micropulse transscleral Laser (CYCLO G6) as a primary surgical procedure for glaucoma. J Glaucoma 2020; 29: 205–210. DOI:https://doi.org/10.1097/ijg.0000000000001426

11.

Preda

Karancsi

Munteanu

, et al. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci 2020; 35: 1487–1491. DOI:https://doi.org/10.1007/s10103-019-02934-x

12.

Wong

KYT

Aquino

Macasaet

, et al. MP3 Plus: a modified micropulse transscleral cyclophototherapy technique for the treatment of refractory glaucoma. J Glaucoma 2020; 29: 264–270. DOI:https://doi.org/10.1097/ijg.0000000000001443

13.

de Crom

Slangen

Kujovic-Aleksov

, et al. Micropulse trans-scleral cyclophotocoagulation in patients with glaucoma: 1- and 2-year treatment outcomes. J Glaucoma 2020; 29: 794–798. DOI:https://doi.org/10.1097/ijg.0000000000001552

14.

Emanuel

Grover

Fellman

, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma 2017; 26: 726–729. DOI:https://doi.org/10.1097/ijg.0000000000000715

15.

Varikuti

VNV

Shah

Rai

, et al. Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma 2019; 28: 901–905. DOI:https://doi.org/10.1097/ijg.0000000000001339

16.

Williams

Moster

Rahmatnejad

, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma 2018; 27: 445–449. DOI:https://doi.org/10.1097/ijg.0000000000000934

17.

Jammal

Costa

Vasconcellos

JPC

, et al. Prospective evaluation of micropulse transscleral diode cyclophotocoagulation in refractory glaucoma: 1 year results. Arq Bras Oftalmol 2019; 82: 381–388. DOI:https://doi.org/10.5935/0004-2749.20190076

18.

Magacho

Lima

Ávila

. Double-session micropulse transscleral laser (CYCLO G6) for the treatment of glaucoma. Lasers Med Sci 2020; 35: 1469–1475. DOI:https://doi.org/10.1007/s10103-019-02922-1

19.

Garcia

Nguyen

Yelenskiy

, et al. Micropulse transscleral diode laser cyclophotocoagulation in refractory glaucoma: short-term efficacy, safety, and impact of surgical history on outcomes. Ophthalmol Glaucoma 2019; 2: 402–412. DOI:https://doi.org/10.1016/j.ogla.2019.08.009

20.

Radhakrishnan

Wan

Tran

, et al. Micropulse cyclophotocoagulation: a multicenter study of efficacy, safety, and factors associated with increased risk of complications. J Glaucoma 2020; 29: 1126–1131. DOI:https://doi.org/10.1097/ijg.0000000000001644

21.

Sarrafpour

Saleh

Ayoub

, et al. Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma 2019; 2: 167–171. DOI:https://doi.org/10.1016/j.ogla.2019.02.002

22.

Tekeli

Köse

. Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma. Eur J Ophthalmol 2021; 31: 1113–1121. DOI:https://doi.org/10.1177/1120672120914231

23.

Yelenskiy

Gillette

Arosemena

, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma 2018; 27: 920–925. DOI:https://doi.org/10.1097/ijg.0000000000001023

24.

Grippo

Töteberg-Harms

Giovingo

, et al. Evidence-Based consensus guidelines series for MicroPulse transscleral Laser therapy – surgical technique, post-operative care, expected outcomes and retreatment/enhancements. Clin Ophthalmol 2023; 17: 71–83. DOI:https://doi.org/10.2147/opth.S389198

25.

Balendiran

Landreneau

. Micropulse transscleral Laser therapy dosimetry utilizing the revised P3 delivery device: a randomized controlled trial. Ophthalmol Glaucoma 2023; 6: 283–290. DOI:https://doi.org/10.1016/j.ogla.2022.09.004

26.

Marchand

Singh

Agoumi

. Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Can J Ophthalmol 2021; 56: 371–378. DOI:https://doi.org/10.1016/j.jcjo.2021.01.015

27.

Number Picker Wheel, https://pickerwheel.com/tools/random-number-generator/.

28.

Glaucoma ICD-10-CM Quick Reference Guide.

29.

Grippo

Sanchez

Stauffer

, et al. Micropulse(®) transscleral laser therapy – fluence may explain variability in clinical outcomes: a literature review and analysis. Clin Ophthalmol 2021; 15: 2411–2419. DOI:https://doi.org/10.2147/opth.S313875

30.

Shaarawy

Sherwood

Grehn

. WGA Guidelines on Design and Reporting of Glaucoma Surgical Trials. Amsterdam, The Netherlands: Kugler Publications, 2009.

31.

Akiyama

Fujishiro

Sugimoto

, et al. Short-term outcomes of micropulse transscleral laser therapy using the revised delivery probe in refractory glaucoma. Jpn J Ophthalmol 2022; 66: 549–558. DOI:https://doi.org/10.1007/s10384-022-00938-9

32.

Aquino

Barton

Tan

, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol 2015; 43: 40–46. DOI:https://doi.org/10.1111/ceo.12360

33.

Issiaka

Zrikem

McHachi

, et al. Micropulse diode laser therapy in refractory glaucoma. Adv Ophthalmol Pract Res 2023; 3: 23–28. DOI:https://doi.org/10.1016/j.aopr.2022.10.003

34.

Agnifili

Palamini

Brescia

, et al. Uveoscleral outflow routes after MicroPulse laser therapy for refractory glaucoma: an optical coherence tomography study of the sclera. Int J Mol Sci 2024; 25: 20240529. DOI:https://doi.org/10.3390/ijms25115913

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.05 MB

Safety and efficacy of MicroPulse transscleral laser therapy with the revised P3 delivery device: A randomized controlled trial

Abstract

Objective

Design

Participants

Methods

Results

Conclusions

Keywords

Get full access to this article

References

Supplementary Material